Literature DB >> 23206463

The effects of epidural anaesthesia and analgesia on natural killer cell cytotoxicity and cytokine response in patients with epithelial ovarian cancer undergoing radical resection.

H Dong1, Y Zhang, H Xi.   

Abstract

OBJECTIVE: Epidural anaesthesia appears to promote antitumourigenic activity in patients with malignant disease who are undergoing surgery. This study investigated immune function in women with epithelial ovarian cancer undergoing radical resection with either general anaesthesia alone or in combination with epidural anaesthesia.
METHODS: Patients (n = 61) were randomized to receive either combined general/epidural anaesthesia (study group) or general anaesthesia alone (control group). Natural killer cell cytotoxicity (NKCC) and serum concentrations of four cytokines (interleukin [IL]-1β, -8 and -10 and interferon [IFN]-γ) were measured before anaesthesia (T(pre)) and 4 h after skin incision (T(4 h)) in both groups.
RESULTS: In both groups, concentrations of protumourigenic cytokines (IL-1β and IL-8) were significantly higher at T(4 h) than at T(pre), while concentrations of antitumourigenic cytokines (IL-10 and IFN-γ) and NKCC were significantly lower at T(4 h). The study group had significantly higher NKCC, IL-10 and IFN-γ levels and lower IL-1β and IL-8 levels at T(4 h) compared with the control group.
CONCLUSION: Combined general/epidural anaesthesia appeared to promote antitumourigenic NKCC and cytokine responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206463     DOI: 10.1177/030006051204000520

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  Comparing the Effects of Combined General/Epidural Anaesthesia and General Anaesthesia on Serum Cytokine Levels in Radical Cystectomy.

Authors:  Meltem Savran Karadeniz; Orkhan Mammadov; Hayriye Şentürk Çiftci; Sebahat Akgül Usta; Kamil Pembeci
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-08-01

2.  Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer.

Authors:  Jill H Tseng; Renee A Cowan; Anoushka M Afonso; Qin Zhou; Alexia Iasonos; Narisha Ali; Errika Thompson; Yukio Sonoda; Roisin E O'Cearbhaill; Dennis S Chi; Nadeem R Abu-Rustum; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2018-09-02       Impact factor: 5.482

Review 3.  Epigenetics in the perioperative period.

Authors:  P Lirk; H Fiegl; N C Weber; M W Hollmann
Journal:  Br J Pharmacol       Date:  2015-04-27       Impact factor: 8.739

4.  Effect of dexmedetomidine anesthesia on perioperative levels of TNF-α and IL-6 in patients with ovarian cancer.

Authors:  Maodong Liu; Yusheng Yi; Mingqiang Zhao
Journal:  Oncol Lett       Date:  2019-04-12       Impact factor: 2.967

Review 5.  Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer.

Authors:  Alejandra Wu Chuang; Oliver Kepp; Guido Kroemer; Lucillia Bezu
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244

Review 6.  Impact of Local Anesthetics on Cancer Behavior and Outcome during the Perioperative Period: A Review.

Authors:  Alain Borgeat; José Aguirre
Journal:  Medicina (Kaunas)       Date:  2022-06-30       Impact factor: 2.948

Review 7.  Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes.

Authors:  Juan P Cata; Claudius Conrad; Katy Rezvani
Journal:  Scientifica (Cairo)       Date:  2015-10-21

8.  Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.

Authors:  R E Kast
Journal:  Springerplus       Date:  2015-10-23

9.  Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy.

Authors:  Xin-Rui Han; Xin Wen; Yan-Yi Li; Shao-Hua Fan; Zi-Feng Zhang; Hong Li; Xing-Feng Sun; Gui-Qi Geng; Shen Sun; Shao-Qiang Huang; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Biosci Rep       Date:  2017-10-24       Impact factor: 3.976

10.  Dexmedetomidine Regulates Proliferation, Apoptosis, Migration, and Invasion in Ovarian Cancer Cells via MiR-155-HIF-1α Axis.

Authors:  Lihong Zheng; Ruimei Jia; Juan Zhao
Journal:  Med Sci Monit       Date:  2019-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.